CompanyDeals

AbbVie to Acquire Cerevel Therapeutics for $8.7 Billion, Strengthening Neuroscience Portfolio

CompanyDrug

Shenzhen TargetRx’s TGRX-678 Set to Receive Breakthrough Therapy Designation for CML-AP

CompanyDeals

Quinovare Partners with AIM Vaccine to Enhance Vaccine Accessibility in China

CompanyDeals

Hisilicon Medical Technology Secures Nearly RMB 100 Million in Series A Funding

CompanyDrug

Changchun BCHT Secures NMPA Approval for Freeze-Dried Human Rabies Vaccine Trials

CompanyDrug

Shanghai Pharmaceuticals Gains NMPA Approval for WST04 Clinical Trials in Oncology

CompanyDrug

Jiangsu Hengrui Seeks NMPA Approval for Camrelizumab-Famitinib Combo in Cervical Cancer

CompanyDeals

Boehringer Ingelheim Partners with Ten63 Therapeutics to Discover Novel Drug Molecules

CompanyDrug

Antengene Secures NDA Approval for Xpovio in Macau for Advanced Multiple Myeloma

CompanyDeals

Innovent Biologics Expands Partnership with Synaffix for New ADC Development

CompanyDeals

Taiwan Bio and TRACT Therapeutics Forge Partnership to Combat Organ Rejection

Company

Pfizer Allegedly Disbands Prevenar 13 Team in China Amid Industry Competition